Georgios Kimourtzis

The elimination of chronic pain is a worthy pursuit and the development of efficacious, non-addictive and long-lasting therapies is the means to achieve this. My interests therefore lie within molecular neuroscience and drug development in the context of pain and somatosensation. For my doctoral work in London,   I established with my collaborators an organ-on-a-chip microfluidic culture platform between neurons of the peripheral and central nervous system to enable the discovery of novel analgesic targets, and subsequently studied the plasticity that governs their excitability. My post-doctoral work with Prof Clifford Woolf at Harvard examined the mechanisms of human stem cell-derived sensory neuron physiology, axonal regeneration, neuropeptide signaling and ion channel sequestration. In the Ernfors group, my work is focused on identifying promising analgesic targets for chronic pain states using microfluidic techniques, functional studies and single cell-RNA sequencing technologies.

• Pain & Somatosensation
• Neuroscience
• Biotechnology
• Drug Discovery
• Microfluidics
• Ion Channels
• Neuronal plasticity 
• Peripheral & Central Sensitization